Camp4 Therapeutics Corp (CAMP) — research page
US · us-cm-kg/NASDAQ/CAMP · as of 2026-11-08
Identity and listing
Camp4 Therapeutics Corp is listed on NASDAQ under the ticker CAMP, with ISIN US13463J1016. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Camp4 Therapeutics Corp | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | CAMP | source · 2026-11-08 |
| ISIN | US13463J1016 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 73 filings across 36 filing days in the window from 2025-11-08 to 2026-11-08. The filings comprise 27 directors' dealings, 20 regulatory filings, 8 corporate news, 6 prospectuses, 6 results, 2 AGM/EGM, 2 director changes, 1 ad hoc and 1 takeover. The median gap between filing days is 6 days. The latest filing is of type results, dated 2026-11-05, 3 days before the record date. The NASDAQ median filings are 52, the median cadence gap is 6.0 days and the median latency is 5.0 days across 4359 issuers. The 2834 Pharmaceutical Preparations sector median filings are 63.0, the median cadence gap is 6.0 days and the median latency is 4.0 days across 526 issuers. The issuer's filings count of 73 is above the NASDAQ median of 52 and above the sector median of 63.0.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 73 | 6 | 3 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | results | 10-Q | 10-Q — 10-Q |
| 2026-11-05 | ad_hoc | 8-K | 8-K — 8-K (items 9.01) |
| 2026-11-05 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-09-28 | corporate_news | 8-K | 8-K — 8-K (items 7.01,8.01,9.01) |
| 2026-09-02 | directors_dealings | 4 | 4 — FORM 4 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Ernst & Young LLP, located in Boston, Massachusetts. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read. The count is 0.
Open research
No openly published research notes were found. The count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer is held in sealed years 2021, 2022, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001736730.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/CAMP (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1736730/000173673026000016/camp-20251231.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/CAMP (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US13463J1016"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:44ac1ceb3e205c69.